Does AMIVANTAMAB-VMJW Cause Off label use? 130 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 130 reports of Off label use have been filed in association with AMIVANTAMAB-VMJW. This represents 6.5% of all adverse event reports for AMIVANTAMAB-VMJW.
130
Reports of Off label use with AMIVANTAMAB-VMJW
6.5%
of all AMIVANTAMAB-VMJW reports
17
Deaths
20
Hospitalizations
How Dangerous Is Off label use From AMIVANTAMAB-VMJW?
Of the 130 reports, 17 (13.1%) resulted in death, 20 (15.4%) required hospitalization, and 3 (2.3%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMIVANTAMAB-VMJW. However, 130 reports have been filed with the FAERS database.
What Other Side Effects Does AMIVANTAMAB-VMJW Cause?
Infusion related reaction (509)
Rash (315)
Dyspnoea (81)
Paronychia (78)
Nausea (65)
Oxygen saturation decreased (55)
Flushing (54)
Death (53)
Non-small cell lung cancer (51)
Fatigue (46)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which AMIVANTAMAB-VMJW Alternatives Have Lower Off label use Risk?
AMIVANTAMAB-VMJW vs AMLODIPINE
AMIVANTAMAB-VMJW vs AMLODIPINE BESILATE
AMIVANTAMAB-VMJW vs AMLODIPINE\ATORVASTATIN
AMIVANTAMAB-VMJW vs AMLODIPINE\BENAZEPRIL
AMIVANTAMAB-VMJW vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN